Search research articles
Contact Us
Filters
Showing results (1-10 of 224) with videos related to
Page
of 23
Sort By:
Nature Reviews. Endocrinology
|
October 31, 2020
Surufatinib - a novel oral agent for neuroendocrine tumours
Anna Koumarianou, Gregory Kaltsas
The Journal of Clinical Endocrinology and Metabolism
|
September 20, 2021
Plasma Polyamines as an Additional to Imaging Biomarker in MEN1 Patients With Duodenopancreatic Neuroendocrine Tumors
Eva Kassi, Gregory Kaltsas
Frontiers of Hormone Research
|
August 26, 2015
Clinical Syndromes Related to Gastrointestinal Neuroendocrine Neoplasms
Georgios Boutzios, Gregory Kaltsas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2013
Bevacizumab plus temozolomide: a novel treatment option for advanced neuroendocrine tumors?
Anna Koumarianou, Gregory Kaltsas
Neuroendocrinology
|
September 11, 2010
Skeletal diseases in Cushing's syndrome: osteoporosis versus arthropathy
Gregory Kaltsas, Polyzois Makras
Best Practice & Research. Clinical Gastroenterology
|
April 16, 2013
Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
George Kanakis, Gregory Kaltsas
Endocrine
|
January 2, 2015
Langerhans cell histiocytosis and pituitary function
Polyzois Makras, Gregory Kaltsas
Clinical Endocrinology
|
September 27, 2005
Post-SARS sickness syndrome manifestations and endocrinopathy: how, why, and so what?
George P Chrousos, Gregory Kaltsas
Clinical Endocrinology
|
June 9, 2015
The expanding role of somatostatin analogues in the treatment of neuroendocrine tumours: the CLARINET study
Gregory Kaltsas, Ashley B Grossman
Endocrine
|
November 30, 2011
Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy
Krystallenia I Alexandraki, Gregory Kaltsas
Page
of 23
Search research articles
Search
Showing results (1-10 of 224) with videos related to
Sort By:
Page
of 23
Nature Reviews. Endocrinology
|
October 31, 2020
Surufatinib - a novel oral agent for neuroendocrine tumours
Anna Koumarianou, Gregory Kaltsas
The Journal of Clinical Endocrinology and Metabolism
|
September 20, 2021
Plasma Polyamines as an Additional to Imaging Biomarker in MEN1 Patients With Duodenopancreatic Neuroendocrine Tumors
Eva Kassi, Gregory Kaltsas
Frontiers of Hormone Research
|
August 26, 2015
Clinical Syndromes Related to Gastrointestinal Neuroendocrine Neoplasms
Georgios Boutzios, Gregory Kaltsas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2013
Bevacizumab plus temozolomide: a novel treatment option for advanced neuroendocrine tumors?
Anna Koumarianou, Gregory Kaltsas
Neuroendocrinology
|
September 11, 2010
Skeletal diseases in Cushing's syndrome: osteoporosis versus arthropathy
Gregory Kaltsas, Polyzois Makras
Best Practice & Research. Clinical Gastroenterology
|
April 16, 2013
Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
George Kanakis, Gregory Kaltsas
Endocrine
|
January 2, 2015
Langerhans cell histiocytosis and pituitary function
Polyzois Makras, Gregory Kaltsas
Clinical Endocrinology
|
September 27, 2005
Post-SARS sickness syndrome manifestations and endocrinopathy: how, why, and so what?
George P Chrousos, Gregory Kaltsas
Clinical Endocrinology
|
June 9, 2015
The expanding role of somatostatin analogues in the treatment of neuroendocrine tumours: the CLARINET study
Gregory Kaltsas, Ashley B Grossman
Endocrine
|
November 30, 2011
Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy
Krystallenia I Alexandraki, Gregory Kaltsas
Page
of 23